If approved,Sunvozertinib as a single oral drug would offer a convenient and safe treatment option with superior efficacy for NSCLC patients with EGFR exon20ins
Midwest hub to support Massimo\'s robust network of partners and customers in the region GARLAND,Texas,Jan. 7,2025--Massimo Group(NASDAQ: MAMO) ("Massimo"),a manufacturer and distributor of
SANTA MONICA,Calif.,Jan. 7,2025-- EarFun,a global leader in wireless audio technology,is set to make waves atCES 2025 with the debut of an impressive lineup of innovative products. From reimagined ope
CHICAGO,Jan. 7,2025--Pudu Robotics,a global leader in service robotics sector,and Burroughs,North America\'s largest independent services provider of unattended self-service technology,robotic automa
PASSIGNANO SUL TRASIMENO,Italy,Jan. 7,2025-- ART,for the first time participates in the Consumer Electronics Show (CES) in Las Vegas,to present its innovative portfolio in the realm of connected infot
Marking a new era of work efficiency,the innovative smart office tools are available at a 5% discount for a limited time.
